Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
3(50%)
Results Posted
150%(3 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
1
17%
Ph phase_1
5
83%

Phase Distribution

5

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
5(83.3%)
Phase 2Efficacy & side effects
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (83.3%)
Phase 21 (16.7%)

Trials by Status

active_not_recruiting117%
completed233%
recruiting233%
terminated117%

Recent Activity

3 active trials
Showing 5 of 6
recruitingphase_1

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

NCT05748197
active_not_recruitingphase_1

A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma

NCT05574114
completedphase_1

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

NCT02356159
recruitingphase_2

Cord Blood Transplant in Adults With Blood Cancers

NCT05884333
terminatedphase_1

Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors

NCT00582816
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05748197Phase 1

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Recruiting
NCT05574114Phase 1

A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma

Active Not Recruiting
NCT02356159Phase 1

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Completed
NCT05884333Phase 2

Cord Blood Transplant in Adults With Blood Cancers

Recruiting
NCT00582816Phase 1

Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors

Terminated
NCT00520130Phase 1

Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6